NorthWest Biotherapeutics Inc (NWBO)

[Horseb4CarT]

I’ll take the express bus, where the initial GBM indication is fast tracked in the US and/or approved in the UK, and a buyer with deep pockets would own nwbo interests in the patents and have the resources to advance the platform relatively quickly across combos and indications.

Especially if you’re a Merck type BP that’s well positioned to promote the DCVax-Keytruda combo treatment.

$10-$15+ per share if nwbo gets to $5 quickly on its own.

Anyway all buses and stops are positive in my book!